BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//KESHO - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:KESHO
X-ORIGINAL-URL:https://kesho-kenya.org
X-WR-CALDESC:Events for KESHO
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Nairobi
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
TZNAME:EAT
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20260521T190000
DTEND;TZID=Africa/Nairobi:20260521T203000
DTSTAMP:20260526T222838
CREATED:20260525T210458Z
LAST-MODIFIED:20260525T210536Z
UID:41677-1779390000-1779395400@kesho-kenya.org
SUMMARY:Bladder Cancer Care
DESCRIPTION:SPEAKERS: Dr. Patrick Mbuthia\, Dr. Helena Musau\, Dr Mohammed Ezzi\nDate: 21st May 2026\nModerator: Dr. Sitna Mwanzi \nThis session examined bladder cancer through a multidisciplinary lens\, bringing together surgical\, radiotherapeutic and systemic treatment perspectives across the continuum of care. \nA central theme was the need for accurate staging and risk-adapted management. Dr. Patrick Mbuthia discussed the role of transurethral resection of bladder tumour (TURBT) in diagnosis\, staging and treatment\, particularly for non-muscle invasive disease. The importance of complete resection\, adequate detrusor muscle in the specimen\, careful imaging and attention to complications was emphasized as central to subsequent treatment decisions. \nDr. Helena Musau highlighted the evolving role of radiotherapy in bladder preservation\, especially through tri-modality therapy combining maximal TURBT\, concurrent chemoradiation and structured response assessment. The discussion also addressed patient selection\, surveillance\, salvage options\, palliative radiotherapy for symptoms\, and the value of newer radiotherapy techniques in reducing toxicity while preserving quality of life. \nDr. Mohammed Ezzi reviewed systemic treatment across non-muscle invasive\, muscle invasive and metastatic bladder cancer. He outlined the role of intravesical therapy\, BCG\, cisplatin eligibility\, immunotherapy\, maintenance strategies and emerging options such as antibody-drug conjugates and targeted agents\, while noting that cost and availability continue to shape real-world treatment in Kenya. \nAcross the session\, a consistent message emerged: improving bladder cancer outcomes requires timely diagnosis\, high-quality TURBT\, multidisciplinary decision-making and treatment pathways that reflect both evidence and local access reality. \nKey Takeaways \n\nBladder cancer management depends on accurate staging and distinction between non-muscle invasive and muscle invasive disease.\nHigh-quality TURBT with adequate muscle sampling is central to diagnosis and treatment planning.\nTrimodality therapy offers bladder preservation for carefully selected patients.\nSystemic therapy is rapidly evolving with immunotherapy\, maintenance approaches and antibody-drug conjugates.\nLocal data are needed to address African patterns of disease\, including schistosomiasis-associated squamous cell carcinoma.\n\n 
URL:https://kesho-kenya.org/event/bladder-cancer-care/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2026/05/Bladder-Cancer-Care.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20260526T080000
DTEND;TZID=Africa/Nairobi:20260526T170000
DTSTAMP:20260526T222838
CREATED:20260526T192731Z
LAST-MODIFIED:20260526T192731Z
UID:41708-1779782400-1779814800@kesho-kenya.org
SUMMARY:The Role of Multimodal Treatment in Esophageal Cancer
DESCRIPTION:Moderator: Dr. Omar Abdihamid\nSpeakers: Dr. Juma Odoro\, Dr. Rogers Mongare\, Dr. Kevin Makori\nDate: 9 April 2026\n\nThis session examined esophageal cancer management through a multidisciplinary lens\, bringing together surgical\, radiotherapeutic and systemic treatment perspectives across the continuum of care. \nA central theme was that treatment selection depends on accurate staging\, patient fitness\, disease burden and early alignment between disciplines. In many African settings\, patients may present with locally advanced disease and nutritional compromise\, making timely diagnosis\, staging and supportive care central to outcomes. \nThe surgical discussion focused on the role of resection in appropriately selected patients\, where careful assessment of resectability\, operative risk\, nodal disease and perioperative optimisation shape whether surgery can offer curative benefit. The session also reinforced that surgery is rarely a standalone decision; it must be integrated with oncology input and long-term follow-up. \nRadiotherapy was addressed as part of multimodal care\, with roles in neoadjuvant\, definitive\, adjuvant and palliative pathways depending on stage and patient factors. The discussion highlighted the need for precise planning\, symptom control and realistic treatment pathways that reflect available infrastructure and patient access. \nIn metastatic disease\, systemic therapy remains central\, with evolving use of combination approaches\, targeted treatment and biomarker-directed strategies. However\, implementation must be balanced with access\, cost\, toxicity\, performance status and local service realities. \nAcross the session\, a consistent message emerged: esophageal cancer care requires deliberate sequencing—matching the right treatment to the right patient at the right point in the disease course. \nKey Takeaways\n\nEsophageal cancer management depends on accurate staging\, nutrition assessment and multidisciplinary planning.\nSurgery remains important in resectable disease but requires careful patient selection and perioperative optimisation.\nRadiotherapy has curative\, consolidative and palliative roles within multimodal treatment.\nMetastatic disease management is evolving with systemic combinations and biomarker-driven options.\nAccess\, treatment tolerance and supportive care shape real-world implementation in Kenya and the wider region.\nEarly referral and MDT decision-making are critical to improving outcomes.
URL:https://kesho-kenya.org/event/the-role-of-multimodal-treatment-in-esophageal-cancer/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/png:https://kesho-kenya.org/wp-content/uploads/2026/05/The-Role-of-Multimodal-Treatment-in-Esophageal-Cancer.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20260528T190000
DTEND;TZID=Africa/Nairobi:20260528T203000
DTSTAMP:20260526T222838
CREATED:20260525T190142Z
LAST-MODIFIED:20260526T114254Z
UID:41658-1779994800-1780000200@kesho-kenya.org
SUMMARY:Advancing Care Through Multidisciplinary Collaboration
DESCRIPTION:The Brain Tumour JourneyAdvancing Care Through Multidisciplinary Collaboration \nDate: 28th May 2026Time: 7 PM – 8:30 PM EATwww.kesho-kenya.org \nSpeakers & Topics\nDr. Michael MagohaConsultant Neurological Surgeon & Lecturer\, University of Nairobi\, Co-Founder Brain Tumor Association of KenyaThe Beginning of the Brain Tumor Journey – A Neurosurgeon’s Perspective \nDr. Sarah MumaPaediatric Haemato-Oncologist\, Kenyatta National HospitalMultidisciplinary Management of Brain Tumors: Optimizing Outcomes Through Collaborative Care \nParmenas Minda OkwemaSenior Lecturer\, Department of Human Pathology\, University of Nairobi\, Chairman and Founder\, Brain Tumor Association of KenyaUnderstanding Brain Tumour Diagnosis: Pathology Principles and Diagnostic Challenges \nRN Celine KilanyaPaediatric Oncology Nurse\, Kenyatta National HospitalHolistic and Supportive Care in Brain Tumour Management: The Oncology Nurse’s Role in Patient Navigation \nMr. David L. Oluoch-Olunya (Moderator)Consultant Neurological Surgeon\, The Nairobi Hospital & Senior Lecturer\, Aga Khan University Hospital \n    	\n        CLICK TO REGISTER
URL:https://kesho-kenya.org/event/advancing-care-through-multidisciplinary-collaboration/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2026/05/WhatsApp-Image-2026-05-26-at-8.18.55-AM.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20261119T080000
DTEND;TZID=Africa/Nairobi:20261121T170000
DTSTAMP:20260526T222838
CREATED:20260407T183641Z
LAST-MODIFIED:20260519T095620Z
UID:41566-1795075200-1795280400@kesho-kenya.org
SUMMARY:The 9th Kenya International Cancer Conference
DESCRIPTION:
URL:https://kesho-kenya.org/event/2026-kenya-international-cancer-conference/
CATEGORIES:Conferences,Webinar Recording Available
END:VEVENT
END:VCALENDAR